Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Gastrointestinal Cancer Excellence Forum

Gastrointestinal Cancer
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Yelena Janjigian, MD, Discusses HER2-Targeting Updates for Metastatic/Locally Advanced Esophageal, Gastric Cancers
Videos
Yelena Janjigian, MD, Discusses HER2-Targeting Updates for Metastatic/Locally Advanced Esophageal, Gastric Cancers
07/28/2020
Dr Janjigian shares her perspective on HER2-targeted therapy data from the DELIVER, KEYNOTE-061, DESTINY-Gastric01, and RTOG1010 trials.
Dr Janjigian shares her perspective on HER2-targeted therapy data from the DELIVER, KEYNOTE-061, DESTINY-Gastric01, and RTOG1010 trials.
Dr Janjigian shares her...
07/28/2020
Oncology
Christopher Crane, MD, Debates Benefits of Long- vs Short-Course RT for Rectal Cancer
Podcasts
Christopher Crane, MD, Debates Benefits of Long- vs Short-Course RT for Rectal Cancer
07/14/2020
Christopher Crane, MD, debates the benefits of long-course radiation therapy over short-course for treatment of rectal cancer at the virtual 2020 Great Debates and Updates in GI Malignancies meeting.
Christopher Crane, MD, debates the benefits of long-course radiation therapy over short-course for treatment of rectal cancer at the virtual 2020 Great Debates and Updates in GI Malignancies meeting.
Christopher Crane, MD, debates...
07/14/2020
Oncology
Anant Ramaswamy, MD, on the Efficacy of Capecitabine-Irinotecan vs Irinotecan for Advanced Gallbladder Cancer
Videos
Anant Ramaswamy, MD, on the Efficacy of Capecitabine-Irinotecan vs Irinotecan for Advanced Gallbladder Cancer
07/01/2020
Dr Ramaswamy provides perspective on a phase 2 trial comparing the efficacy of irinotecan administered with or without capecitabine for advanced gallbladder cancer.
Dr Ramaswamy provides perspective on a phase 2 trial comparing the efficacy of irinotecan administered with or without capecitabine for advanced gallbladder cancer.
Dr Ramaswamy provides...
07/01/2020
Oncology
Keynote on Women in Oncology Aims to Encourage Discourse About Diversity, Inclusivity
Videos
Keynote on Women in Oncology Aims to Encourage Discourse About Diversity, Inclusivity
07/01/2020
Solange Peters, MD, PhD, discusses the motivation behind her Keynote Presentation on women in oncology, which will take place virtually on July 4th at the 2020 ESMO World Congress on GI Cancer.
Solange Peters, MD, PhD, discusses the motivation behind her Keynote Presentation on women in oncology, which will take place virtually on July 4th at the 2020 ESMO World Congress on GI Cancer.
Solange Peters, MD, PhD,...
07/01/2020
Oncology
Axel Grothey, MD, Talks About the Upcoming ESMO World Congress on GI Cancer
Videos
Axel Grothey, MD, Talks About the Upcoming ESMO World Congress on GI Cancer
06/22/2020
Dr Grothey tells us what we can look forward to at the 22nd ESMO World Congress on Gastrointestinal Cancer, which is taking place virtually this year.
Dr Grothey tells us what we can look forward to at the 22nd ESMO World Congress on Gastrointestinal Cancer, which is taking place virtually this year.
Dr Grothey tells us what we can...
06/22/2020
Oncology
Solange Peters, MD, PhD, on What to Expect at the Virtual ESMO World Congress on GI Cancer
Videos
Solange Peters, MD, PhD, on What to Expect at the Virtual ESMO World Congress on GI Cancer
06/21/2020
The President of ESMO discusses what attendees of the annual ESMO World Congress on GI Cancer can expect from the virtual 2020 event.
The President of ESMO discusses what attendees of the annual ESMO World Congress on GI Cancer can expect from the virtual 2020 event.
The President of ESMO discusses...
06/21/2020
Oncology
Pembrolizumab Yields Impressive Ongoing Responses in Treatment-Naive RCC
Videos
Pembrolizumab Yields Impressive Ongoing Responses in Treatment-Naive RCC
06/03/2020
David McDermott, MD, discusses the encouraging follow-up findings of the KEYNOTE-427 clinical trial.
David McDermott, MD, discusses the encouraging follow-up findings of the KEYNOTE-427 clinical trial.
David McDermott, MD, discusses...
06/03/2020
Oncology
Overcoming COVID-19 Hurdles in Routine Clinical Practice
Videos
Overcoming COVID-19 Hurdles in Routine Clinical Practice
04/16/2020
Axel Grothey, MD, talks about how healthcare providers are rising to face the challenges presented by the COVID-19 pandemic in routine clinical practice.
Axel Grothey, MD, talks about how healthcare providers are rising to face the challenges presented by the COVID-19 pandemic in routine clinical practice.
Axel Grothey, MD, talks about...
04/16/2020
Oncology
No Clinical Benefit Adding Pegilodecakin to FOLFOX for Pancreatic Cancer
Podcasts
No Clinical Benefit Adding Pegilodecakin to FOLFOX for Pancreatic Cancer
02/24/2020
Joel Randolph Hecht, MD, discusses findings from the SEQUOIA clinical trial of GEM-refractory pancreatic cancer.
Joel Randolph Hecht, MD, discusses findings from the SEQUOIA clinical trial of GEM-refractory pancreatic cancer.
Joel Randolph Hecht, MD,...
02/24/2020
Oncology
Primary Tumor Resection Plus Chemo Yields No Benefit Over Chemo Alone for Stage IV CRC
Interview
Primary Tumor Resection Plus Chemo Yields No Benefit Over Chemo Alone for Stage IV CRC
02/13/2020
Yukihide Kanemitsu, MD, discusses clinical significance of the JCOG1007 study, the results of which were presented at the 2020 ASCO GI Cancers Symposium.
Yukihide Kanemitsu, MD, discusses clinical significance of the JCOG1007 study, the results of which were presented at the 2020 ASCO GI Cancers Symposium.
Yukihide Kanemitsu, MD,...
02/13/2020
Oncology

Advertisement

Advertisement

Advertisement

Section Editor

Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center, New York

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement